Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control
- PMID: 18709545
- PMCID: PMC3832627
- DOI: 10.1007/s10545-008-0919-5
Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control
Abstract
While the presence of hyperlipidaemia in glycogen storage disease (GSD) type Ia and Ib is generally accepted, few investigators have adequately assessed lipid profiles of GSD III in children, in whom the presence of hyperlipidaemia may be most prominent. We analysed the lipid profiles in 44 GSD III patients from 6 months to 30 years of age. Hypertriglyceridaemia and hypercholesterolaemia were common in children younger than 3 years of age. Hypertriglyceridaemia correlated negatively with age, and may reflect increased severity of hypoglycaemia in this younger population. The presence of hyperlipidaemia during childhood in these patients identifies another GSD population that could be at risk for early cardiovascular disease (CVD). Consequently, the outcome of clinical trials investigating the vascular effect of hyperlipidaemia in GSD applies to types other than GSD I.
Conflict of interest statement
Competing interests: None declared
Figures
References
-
- Bandsma RH, Prinsen BH, van der Velden MD, et al. Increased de novo lipogenesis and delayed conversion of large VLDL into IDL particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res. 2008 Epub ahead of print. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
